Private company

Nicox

Logo: http://www.nicox.com/files/pdf/CR2009EN.pdf, Non-free logo, via Wikipedia4

Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi. Nicox is listed on Euronext Paris (Compartment B: Mid-Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.2 It was founded in 1996.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1996Founded1
  • Industryresearch and development in biotechnology1
  • HeadquartersSophia Antipolis, France1
  • Websitewww.nicox.com
  • Legal formpublic limited company with a board of directors (n.o.s.)1
  • LEI969500EZGEO9W4JXR3533
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressSOPHIA, 06410 Biot, France3
  • Registered withNational Institute of Statistics and Economic Studies, 4039426423

Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.2

Products and brands

  • naproxcinod

Listed on Wikidata.1

Subsidiaries and ownership

Owners

From Wikidata.1

Timeline

  1. 1996Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4